Document:

axim_ex1012.htm

EXHIBIT 10.12
   
 TERMINATION AGREEMENT
  
 This Termination Agreement made as of March 3, 2022 (the “Effective Date”) by and between AXIM Biotechnologies Inc., a Nevada corporation (“AXIM”), and Empowered Diagnostics LLC, a Florida limited liability Company (“Empowered Diagnostics”), who agree to the following, including the Recitals.
  
 RECITALS
  
 A. AXIM and Empowered Diagnostics are parties to that certain Limited License, Manufacture and Distribution Agreement dated as of August 21, 2020 (the “Distribution Agreement”).
  
 B. AXIM and Empowered Diagnostics desire to terminate the Distribution Agreement, effective as of the date hereof.
  
 AGREEMENT
  
 1. Termination. Subject to the provisions of this Agreement, the Distribution Agreement and all rights, interests and obligations of AXIM and Empowered Diagnostics pursuant to the Distribution Agreement shall terminate as of the Effective Date in accordance with Section 9 thereof.
  
 2. Consideration. The consideration for the termination is the parties’ agreement as set forth herein. No other consideration shall be paid by either party to the other in consideration for this termination of the Distribution Agreement.
  
 3. Mutual Waiver and Release. Effective as of Effective Date, each party hereby mutually agree to terminate the Distribution Agreement. From the Effective Date, each party voluntarily and irrevocably releases and discharges the other party and its respective predecessors, parent organizations, directors, officers, shareholders, employees, agents, attorneys, successors, assigns, sureties, and insurers (the “Releasees”) of and from all claims, actions, demands, debts, liabilities, expenses, and causes of action of whatever kind or character, including (but not limited to) contract, tort, and statutory claims, actions, demands, and causes of action (collectively, “Claims”) arising out of or related to the Distribution Agreement which a party had, has, might have, or might claim to have against the Releasees of the other party, for any past, present, and future damages, losses, or expenses whatsoever (collectively, “Damages”) suffered or claimed to have been suffered by a party as a result of any act or failure to act by any of the Releasees of the other party, as of the Effective Date, whether or not such Claims or such Damages are known to a party on or before that date.
  
 4. Waiver of Statutes Regarding Limitations on General Releases and similar laws. To the extent that the foregoing releases are releases to which applicable law limiting general applies, it is the intention of the parties that the foregoing releases shall be effective as a bar to any and all actions, fees, damages, losses, claims, liabilities and demands of whatsoever character, nature and kind, known or unknown, suspected or unsuspected specified herein. In furtherance of this intention, all Releasees expressly waive any and all rights and benefits conferred upon them by the provision of applicable law which may otherwise provide that a general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor.
  
 5. Mutual Non-Disparagement. Each party hereto agrees not to (a) make any false, misleading, or disparaging representations or statements about the other party or its services or products to any person, (b) make any statements that may impair or otherwise adversely affect the other party’s goodwill or reputation, (c) interfere with the other party’s relationships or potential relationships with actual or potential customers, clients, vendors, or employees, or (d) take any actions that might interfere with the other party’s business activities.
  
 6. Representations. Each party represents and warrants that it is fully authorized to enter into this Agreement without the consent of any third party. Each person signing this Agreement represents and warrants that he has been duly authorized and empowered to sign this Agreement on behalf of the party which such person purports to represent and that this Agreement is a lawful and binding obligation of such party.
  
 	 
	 1

	

	 

  
 7. Miscellaneous. The provisions of this Agreement shall inure to the benefit of, and be binding upon, the parties hereto and their respective successors and assigns. This Agreement contains the entire agreement between AXIM and Empowered Diagnostics, and no further agreement between the parties shall be effective unless in writing, and signed by both the parties. In the event any action is brought for breach of this Agreement, or to interpret the provisions thereof, the party that substantially prevails in such action shall be entitled to recover its reasonable attorneys’ fees from the other party.
   
 Dated and effective as of the date set forth above.
    	 AXIM Biotechnologies Inc.
	 Empowered Diagnostics LLC 

	  
	  

	 

   
 	 
	 2Exhibit 4.1

 

	
    NUMBER 

    ASPPU
	 	UNITS

 

	
    SEE REVERSE FOR

    CERTAIN DEFINITIONS
	ABRI SPAC 2, INC.	 

 

CUSIP 00086E 205

 

UNITS CONSISTING OF ONE SHARE OF COMMON STOCK
, ONE WARRANT

EACH WARRANT TO PURCHASE ONE SHARE OF COMMON STOCK AND, AND ONE RIGHT TO

 RECEIVE ONE-TENTH OF ONE SHARE OF COMMON STOCK UPON THE CONSUMMATION
OF AN

 INITIAL BUSINESS COMBINATION.

 

	THIS CERTIFIES THAT	 	 

 

	is the owner of	 	Units.

 

Each Unit (“Unit”) consists
of one (1) share of common stock, par value $0.0001 per share (“Common Stock”), of Abri SPAC 2, Inc., a Delaware
corporation (the “Company”), one warrant (the “Warrant(s)”), and one right to receive
one-tenth of one share of common stock upon the consummation of an initial business combination (“Rights”).
Each Warrant entitles the holder to purchase one share of Common Stock for $11.50 per share (subject to adjustment). Each Warrant will
become exercisable on the later of (i) 30 days after the Company’s completion of a merger, share exchange, asset acquisition, stock
purchase, recapitalization, reorganization or other similar business combination (“Business Combination”) and
(ii) twelve (12) months from the closing of the Company’s initial public offering (“IPO”), and will expire
unless exercised before 5:00 p.m., New York City Time, on the fifth anniversary of the completion of an initial Business Combination,
or earlier upon redemption (the “Expiration Date”). The Common Stock, Warrants and Rights comprising the Units
represented by this certificate are not transferable separately prior to the 90th day after the date of the prospectus relating to the
Company’s IPO, subject to earlier separation in the discretion of Chardan Capital Markets, LLC, provided that the Company has filed
with the Securities and Exchange Commission a Current Report on Form 8-K which includes an audited balance sheet reflecting the Company’s
receipt of the gross proceeds of the IPO and issued a press release announcing when separate trading will begin. The terms of the Warrants
are governed by a warrant agreement (the “Warrant Agreement”), dated as of [●], 2022, between the Company and Continental
Stock Transfer & Trust Company, LLC, as the warrant agent, and are subject to the terms and provisions contained therein, all of which
terms and provisions the holder of this certificate consents to by acceptance hereof. Copies of the Warrant Agreement are on file at the
office of Continental Stock Transfer & Trust Company, LLC at 1 State Street, 30th Floor, New York, NY 10004-1561 and are available
to any Warrant Holder on written request and without cost. The terms of the Rights are governed by a rights agreement (the “Rights
Agreement”), dated as of [●], 2022, between the Company and Continental Stock Transfer & Trust Company, LLC, as the rights
agent, and are subject to the terms and provisions contained therein, all of which terms and provisions the holder of this certificate
consents to by acceptance hereof. Copies of the Rights Agreement are on file at the office of Continental Stock Transfer & Trust Company,
LLC at 1 State Street, 30th Floor, New York, NY 10004-1561 and are available to any Rights Holder on written request and without cost.

 

This certificate is not valid unless countersigned
by the Transfer Agent and Registrar of the Company.

 

Witness the facsimile seal of the Company and the
facsimile signatures of its duly authorized officers.

  

	By	 	 	 
	 	Chairman of the Board	 	Chief Executive Officer

 

     

     

    

 

ABRI SPAC 2, INC.

 

The Company will furnish without
charge to each stockholder who so requests, a statement of the powers, designations, preferences and relative, participating, optional
or other special rights of each class of stock or series thereof of the Company and the qualifications, limitations, or restrictions of
such preferences and/or rights.

 

The following abbreviations,
when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to
applicable laws or regulations:

 

	TEN COM	-	as tenants in common	UNIF GIFT MIN ACT-	 	Custodian	 	 
	TEN ENT	-	as tenants by the entireties	 	 	(Cust)	 	(Minor)	 
	JT TEN	-	as joint tenants with right of survivorship	under Uniform Gifts to Minors	 	 
	 	 	and not as tenants in common	Act	 	 	 	 	 
	 	 	 	 	(State)	 	 	 	 

 

Additional abbreviations may also be used though not in the above list.

	 	 	 	 	 
	For value received,                      hereby sell, assign and transfer unto

  

	
    PLEASE INSERT SOCIAL SECURITY OR OTHER

    IDENTIFYING NUMBER OF ASSIGNEE
	 
	 	 
	
     

     

     
	 

 

	(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE)
	 

 

	 	 	Units

represented by the within Certificate, and do hereby irrevocably
constitute and appoint

 

	 	 	Attorney to transfer

the said Units on the books of the within named Company will full
power of substitution in the premises.

 

Dated____________

 

	 	 
	 	Notice: 	The signature to this assignment must correspond with the name as 

written upon the face of the certificate in every particular, without 

alteration or enlargement or any change whatever.

 

Signature(s) Guaranteed:

	 	 	 
	THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).

 

The holder(s) of this certificate shall be entitled
to receive a pro-rata portion of the funds from the trust account with respect to the common stock underlying this certificate only in
the event that (i) the Company is forced to liquidate because it does not consummate an initial business combination within the period
of time set forth in the Company’s Amended and Restated Certificate of Incorporation, as the same may be amended from time to time
(the “Charter”) or (ii) if the holder seeks to convert his shares upon consummation of, or sell his shares in a tender offer
in connection with, an initial business combination or in connection with certain amendments to the Charter. In no other circumstances
shall the holder(s) have any right or interest of any kind in or to the trust account.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]